» Articles » PMID: 33846553

Ascorbate Deficiency Confers Resistance to Hippocampal Neurodegeneration After Asphyxial Cardiac Arrest in Juvenile Rats

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2021 Apr 13
PMID 33846553
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Asphyxial cardiac arrest (CA) is a significant cause of death and disability in children. Using juvenile Osteogenic disorder Shionogi (ODS) rats that, like humans, do not synthesize ascorbate, we tested the effect of ascorbate deficiency on functional and histological outcome after CA.

Methods: Postnatal day 16-18 milk-fed ODS and wild-type Wistar rats underwent 9-min asphyxial CA (n = 8/group) or sham surgery (n = 4/group). ODS mothers received ascorbate in drinking water to prevent scurvy. Levels of ascorbate and glutathione (GSH) were measured in plasma and hippocampus at baseline and after CA. Neurologic deficit score (NDS) was measured at 3, 24, and 48 h and hippocampal neuronal counts, neurodegeneration, and microglial activation were assessed at day 7.

Results: ODS rats showed depletion of plasma and hippocampal ascorbate, attenuated hippocampal neurodegeneration and microglial activation, and increased CA1 hippocampal neuron survival vs. Wistar rats while NDS were similar. Hippocampal GSH levels were higher in ODS vs. Wistar rats at baseline and 10 min, whereas hypoxia-inducible factor-1α levels were higher in Wistar vs. ODS rats at 24 , after CA.

Conclusion: Ascorbate-deficient juvenile ODS rats appear resistant to neurodegeneration produced by asphyxia CA, possibly related to upregulation of the endogenous antioxidant GSH in brain.

Impact: Like humans and unlike other rodents, osteogenic disorder Shionogi (ODS) rats do not synthesize ascorbate, and thus may serve as a useful model for studying the role of ascorbate in human disease. Conflicting evidence exists regarding ascorbate's protective versus detrimental effects in animal models and clinical studies. Ascorbate-deficient ODS rats are resistant to neurodegeneration after experimental cardiac arrest.

References
1.
Tress E, Kochanek P, Saladino R, Manole M . Cardiac arrest in children. J Emerg Trauma Shock. 2010; 3(3):267-72. PMC: 2938492. DOI: 10.4103/0974-2700.66528. View

2.
Moler F, Silverstein F, Holubkov R, Slomine B, Christensen J, Nadkarni V . Therapeutic hypothermia after out-of-hospital cardiac arrest in children. N Engl J Med. 2015; 372(20):1898-908. PMC: 4470472. DOI: 10.1056/NEJMoa1411480. View

3.
Ichord R, Silverstein F, Slomine B, Telford R, Christensen J, Holubkov R . Neurologic outcomes in pediatric cardiac arrest survivors enrolled in the THAPCA trials. Neurology. 2018; 91(2):e123-e131. PMC: 6053110. DOI: 10.1212/WNL.0000000000005773. View

4.
Harrison F, May J . Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med. 2009; 46(6):719-30. PMC: 2649700. DOI: 10.1016/j.freeradbiomed.2008.12.018. View

5.
Spector R, Eells J . Deoxynucleoside and vitamin transport into the central nervous system. Fed Proc. 1984; 43(2):196-200. View